After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...
Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries from severe long Covid, achieved entirely outside mainstream medicine. The ...
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 June 23, 2026 12:30 PM EDTCompany ParticipantsShaun Bagai - ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access June 15, 2026 5:00 PM EDTCompany ...
Patients with advanced squamous non-small-cell lung cancer who received the bispecific antibody ivonescimab alongside chemotherapy had a 40% lower risk of disease progression or death compared with ...
Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter ...
Slim tide uses Akkermansia muciniphila and prebiotic fibers to support gut health and metabolism. Read the full 2026 slim tide ingredient and safety analysis.
Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results